1. Home
  2. ITOS vs MIY Comparison

ITOS vs MIY Comparison

Compare ITOS & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • MIY
  • Stock Information
  • Founded
  • ITOS 2011
  • MIY 1992
  • Country
  • ITOS United States
  • MIY United States
  • Employees
  • ITOS N/A
  • MIY N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • MIY Investment Bankers/Brokers/Service
  • Sector
  • ITOS Health Care
  • MIY Finance
  • Exchange
  • ITOS Nasdaq
  • MIY Nasdaq
  • Market Cap
  • ITOS 381.2M
  • MIY 312.2M
  • IPO Year
  • ITOS 2020
  • MIY N/A
  • Fundamental
  • Price
  • ITOS $10.17
  • MIY $10.80
  • Analyst Decision
  • ITOS Hold
  • MIY
  • Analyst Count
  • ITOS 6
  • MIY 0
  • Target Price
  • ITOS $10.60
  • MIY N/A
  • AVG Volume (30 Days)
  • ITOS 1.5M
  • MIY 56.8K
  • Earning Date
  • ITOS 08-07-2025
  • MIY 01-01-0001
  • Dividend Yield
  • ITOS N/A
  • MIY 3.98%
  • EPS Growth
  • ITOS N/A
  • MIY N/A
  • EPS
  • ITOS N/A
  • MIY N/A
  • Revenue
  • ITOS $35,000,000.00
  • MIY N/A
  • Revenue This Year
  • ITOS N/A
  • MIY N/A
  • Revenue Next Year
  • ITOS N/A
  • MIY N/A
  • P/E Ratio
  • ITOS N/A
  • MIY N/A
  • Revenue Growth
  • ITOS 177.89
  • MIY N/A
  • 52 Week Low
  • ITOS $4.80
  • MIY $9.45
  • 52 Week High
  • ITOS $18.13
  • MIY $11.70
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 58.43
  • MIY 40.54
  • Support Level
  • ITOS $10.10
  • MIY $10.62
  • Resistance Level
  • ITOS $10.47
  • MIY $11.36
  • Average True Range (ATR)
  • ITOS 0.12
  • MIY 0.12
  • MACD
  • ITOS -0.06
  • MIY 0.00
  • Stochastic Oscillator
  • ITOS 23.08
  • MIY 29.11

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About MIY Blackrock MuniYield Michigan Quality Fund Inc.

Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.

Share on Social Networks: